Literature DB >> 11668472

Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice.

W S Shim1, M Teh, P O Mack, R Ge.   

Abstract

Angiopoietin-1 (Ang1) is an angiogenic growth factor that functions through activation of its endothelium-specific tyrosine kinase receptor Tie2; it mediates the interaction between endothelial and surrounding cells to promote the remodeling, maturation and stabilization of blood vessels. Although Ang1 is expressed constitutively in many adult tissues, its role in tumor growth and metastasis is not clear. Here we describe experiments in which Ang1 expression was inhibited in HeLa cells by an antisense RNA approach. The modified HeLa cells produced significantly less Ang1 protein both in cultured cells and in tumors formed when these cells were injected into immunodeficient mice. The Ang1 antisense tumors grew much more slowly, with significantly reduced tumor angiogenesis compared with control tumors. Furthermore, they also had substantially increased tumor cell apoptosis and decreased tumor necrosis. Our results indicate that the perturbation of Ang1 expression in tumors could be an effective method to control tumor growth by inhibiting tumor angiogenesis and that antisense RNA is an efficient way to inhibit Ang1 protein production in tumor cells. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668472     DOI: 10.1002/ijc.1428

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Unique angiogenic and vasculogenic properties of renal cell carcinoma in a xenograft model of bone metastasis are associated with high levels of vegf-a and decreased ang-1 expression.

Authors:  Chao Xie; Edward M Schwarz; Erik R Sampson; Robinder S Dhillon; Dan Li; Regis J O'Keefe; Wakenda Tyler
Journal:  J Orthop Res       Date:  2011-08-01       Impact factor: 3.494

2.  PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2-mediated arteriogenesis, mast cell accumulation, and fibrosis.

Authors:  Robinder S Dhillon; Chao Xie; Wakenda Tyler; Laura M Calvi; Hani A Awad; Michael J Zuscik; Regis J O'Keefe; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

3.  Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model.

Authors:  Marcia Regina Machein; Anette Knedla; Rolf Knoth; Shawn Wagner; Elvira Neuschl; Karl H Plate
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

4.  Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1/2-neutralizing peptibody.

Authors:  Angela Coxon; James Bready; Hosung Min; Stephen Kaufman; Juan Leal; Dongyin Yu; Tani Ann Lee; Ji-Rong Sun; Juan Estrada; Brad Bolon; James McCabe; Ling Wang; Karen Rex; Sean Caenepeel; Paul Hughes; David Cordover; Haejin Kim; Seog Joon Han; Mark L Michaels; Eric Hsu; Grant Shimamoto; Russell Cattley; Eunju Hurh; Linh Nguyen; Shao Xiong Wang; Anthony Ndifor; Isaac J Hayward; Beverly L Falcón; Donald M McDonald; Luke Li; Tom Boone; Richard Kendall; Robert Radinsky; Jonathan D Oliner
Journal:  Mol Cancer Ther       Date:  2010-10       Impact factor: 6.261

5.  A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor.

Authors:  Roselyne Tournaire; Marie-Pierre Simon; Ferdinand le Noble; Anne Eichmann; Patrick England; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2004-02-20       Impact factor: 8.807

6.  Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis.

Authors:  Woo Sung Moon; Ho Sung Park; Ki Hoon Yu; Kyu Yun Jang; Myoung Jae Kang; Harry Park; Andrzej S Tarnawski
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

7.  Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.

Authors:  Beverly L Falcón; Hiroya Hashizume; Petros Koumoutsakos; Jeyling Chou; James V Bready; Angela Coxon; Jonathan D Oliner; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

8.  A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function.

Authors:  Rebekah R White; Julie A Roy; Kristi D Viles; Bruce A Sullenger; Christopher D Kontos
Journal:  Angiogenesis       Date:  2008-11-27       Impact factor: 9.596

9.  Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma.

Authors:  May Elbanna; Ashley R Orillion; Nur P Damayanti; Remi Adelaiye-Ogala; Li Shen; Kiersten Marie Miles; Sreenivasulu Chintala; Eric Ciamporcero; Swathi Ramakrishnan; Sheng-Yu Ku; Karen Rex; Sean Caenepeel; Angela Coxon; Roberto Pili
Journal:  Mol Cancer Ther       Date:  2019-10-03       Impact factor: 6.261

10.  A new liver metastatic and peritoneal dissemination model established from the same human pancreatic cancer cell line: analysis using cDNA macroarray.

Authors:  Hiroki Nomura; Hidefumi Nishimori; Takahiro Yasoshima; Fumitake Hata; Hiroshi Tanaka; Futoshi Nakajima; Toshio Honma; Jun Araya; Kenjiro Kamiguchi; Hiroshi Isomura; Noriyuki Sato; Ryuichi Denno; Koichi Hirata
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.